AMAG Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2, 2018 at 8:00 a.m. ET
26 juil. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its second quarter 2018 financial results will be released on Thursday, August 2, 2018...
AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry®
15 juin 2018 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Transaction Underscores AMAG’s Focus on Clinical Development and Commercialization of Pharmaceuticals Company Intends to Use the Majority of Proceeds to Pay off High-Yield Debt WALTHAM, Mass., June ...
AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies
11 juin 2018 16h44 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass. and WHITE PLAINS, N.Y., June 11, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and March of Dimes today announced a strategic corporate partnership focused on a...
AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide
04 juin 2018 07h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application...
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
29 mai 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the Jefferies 2018 Healthcare Conference on Tuesday,...
AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopause
09 mai 2018 07h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today commended the recent action taken by the Centers for Medicare and Medicaid Services (CMS) to clarify...
AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance
03 mai 2018 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Strong first quarter execution with two FDA approvals and submission of a new drug application Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) --...
AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer
02 mai 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of J. Alan Butcher as executive vice president and chief business officer...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
27 avr. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: Deutsche...
AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3, 2018 at 8:00 a.m. ET
26 avr. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its first quarter 2018 financial results will be released on Thursday, May 3, 2018...